Free Trial
LON:RLM

Realm Therapeutics (RLM) Share Price, News & Analysis

About Realm Therapeutics Stock (LON:RLM)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
11.50
11.50
52-Week Range
N/A
Volume
169,853 shs
Average Volume
800,861 shs
Market Capitalization
£13.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RLM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Realm Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

RLM Stock News Headlines

EPI:CA ESSA Pharma Inc.
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Defence of the Realm Act (DORA)
Realm Therapeutics PLC ADR (RLM_old)
See More Headlines

RLM Stock Analysis - Frequently Asked Questions

Shares of RLM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Realm Therapeutics investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX) and Ampio Pharmaceuticals (AMPE).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Steel Works
Current Symbol
LON:RLM
Previous Symbol
LON:PURI
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.05
Quick Ratio
9.96

Sales & Book Value

Annual Sales
£501.92 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.57
Book Value
GBX 20.80 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
116,562,000
Free Float
N/A
Market Cap
£13.41 million
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (LON:RLM) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners